Stephan Braun

7.2k total citations · 1 hit paper
136 papers, 4.3k citations indexed

About

Stephan Braun is a scholar working on Oncology, Electrical and Electronic Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stephan Braun has authored 136 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 36 papers in Electrical and Electronic Engineering and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stephan Braun's work include Cancer Cells and Metastasis (41 papers), Electromagnetic Compatibility and Noise Suppression (34 papers) and Electromagnetic Compatibility and Measurements (25 papers). Stephan Braun is often cited by papers focused on Cancer Cells and Metastasis (41 papers), Electromagnetic Compatibility and Noise Suppression (34 papers) and Electromagnetic Compatibility and Measurements (25 papers). Stephan Braun collaborates with scholars based in Germany, Austria and United States. Stephan Braun's co-authors include Klaus Pantel, Wolfgang Janni, F. Hepp, Christina Kentenich, P. Russer, Günter Schlimok, Harald Sommer, G. Riethmüller, Bjørn Naume and Gert Riethmüller and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Stephan Braun

125 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer

2000 726 citations Stephan Braun, Klaus Pantel et al. profile →

Peers

Countries citing papers authored by Stephan Braun

Since Specialization

Citations

This map shows the geographic impact of Stephan Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Braun more than expected).

Fields of papers citing papers by Stephan Braun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Braun. The network helps show where Stephan Braun may publish in the future.

Co-authorship network of co-authors of Stephan Braun

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Braun. A scholar is included among the top collaborators of Stephan Braun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Braun. Stephan Braun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Machine-Learning-Based Approach to Informing Student Admission Decisions 2025 ·Behavioral Sciences ·Tuo Liu, (unknown), Stephan Braun, Andreas Frey	0
2	γ9δ2 T-cell (γ9δ2TC) activation with ICT01 and azacitidine-venetoclax (Aza-Ven) induces high rates of remission and overall survival in patients with newly diagnosed (ND) acute myeloid leukemia (AML): Results from the phase 1/2 study eviction 2025 ·Blood ·Sylvain Garciaz, (unknown), Pierre Péterlin, Daniel Morillo, José Miguel Torregrosa Diaz, Matthew L. Ulrickson, (unknown), Aude De Gassart, (unknown), Maelle Mairesse, George Saad, (unknown), Katrien Lemmens, (unknown), D Olive, Stephan Braun, Naval Daver, Abhishek Maiti	0
3	ICT01, an Investigational γ9δ2 T Cell Activator, Added to Azacitidine-Venetoclax Achieves Frequent and Early Complete Remissions in Adults with AML Unfit for Intensive Induction Chemotherapy: Interim Results from the Ongoing Open-Label, Randomized Phase 1 Study Eviction 2024 ·Blood ·Abhishek Maiti, (unknown), Pierre Péterlin, Daniel Morillo, José Miguel Torregrosa Diaz, Paul Koller, Maelle Mairesse, (unknown), (unknown), Aude De Gassart, Katrien Lemmens, Daniel Olive, Naval Daver, Stephan Braun, Sylvain Garciaz	1
4	Safety and Activity of the First-in-Class Sym004 Anti-EGFR Antibody Mixture in Patients with Refractory Colorectal Cancer 2015 ·Cancer Discovery ·Rodrigo Dienstmann, Amita Patnaik, Rocio García‐Carbonero, Andrés Cervantes, Marta Benavent, Susana Roselló, Bastiaan B.J. Tops, Rachel S. van der Post, Guillem Argilés, (unknown), (unknown), (unknown), Mikkel W. Pedersen, Michael Kragh, Ivan D. Horak, Stephan Braun, Eric Van Cutsem, Anthony W. Tolcher, Josep Tabernero	58
5	Benefit of Adding Panitumumab to FOLFOX4 in Patients with KRAS/NRAS Wild-Type (WT) Metastatic Colorectal Cancer (mCRC): A Number-Needed-To-Treat (NNT) Analysis 2013 ·Value in Health ·Jean‐Yves Douillard, (unknown), (unknown), Stephan Braun, R. Sidhu	1
6	Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse—A European Pooled Analysis 2011 ·Clinical Cancer Research ·Wolfgang Janni, Florian D. Vogl, Gro Wiedswang, Marit Synnestvedt, Tanja Fehm, Julia Jückstöck, Elin Borgen, Brigitte Rack, Stephan Braun, Harald Sommer, Erich Solomayer, Klaus Pantel, Jahn M. Nesland, Klaus Friese, Bjørn Naume	192
7	A Time-Domain EMI Measurement System up to 26 GHz with Multichannel APD Measuring Function 2011 ·(unknown), Christian Hoffmann, Stephan Braun, (unknown), Johannes A. Russer	2
8	A novel multichannel amplitude probability distribution for a time-domain EMI measurement system according to CISPR 16-1-1 2011 ·International Symposium on Electromagnetic Compatibility ·(unknown), Christian Hoffmann, Stephan Braun, P. Russer	9
9	A Broadband Time-Domain EMI Measurement System for Measurements up to 18 GHz 2010 ·Christian Hoffmann, Stephan Braun, P. Russer	5
10	Die Zeit danach vorstellen: Überlebensfiguren bei Goethe, Kleist, Nietzche und Heiner Müller 2009 ·Stephan Braun	0
11	Topographien der Leere : Friedrich Nietzsche, Schreiben und Schrift 2007 ·Königshausen & Neumann eBooks ·Stephan Braun	0
12	Disseminated tumor cells: Are they ready for clinical use? 2007 ·The Breast ·Stephan Braun, Florian D. Vogl, (unknown), Daniel Egle, (unknown), (unknown), Christian Marth	6
13	A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation 2006 ·Cancer ·Tanja Fehm, Stephan Braun, Volkmar Müller, Wolfgang Janni, Gerhard Gebauer, Christian Marth, Christian Schindlbeck, D. Wallwiener, Elin Borgen, Bjørn Naume, Klaus Pantel, Erich Solomayer	177
14	Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIα-status of the primary tumor? 2005 ·Journal of Cancer Research and Clinical Oncology ·Christian Schindlbeck, W Janni, (unknown), (unknown), Brigitte Rack, D. Rjosk, B. Gerber, Stephan Braun, H. Sommer, K Friese	13
15	The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence 2005 ·Cancer ·Wolfgang Janni, Brigitte Rack, Christian Schindlbeck, B. Strobl, D. Rjosk, Stephan Braun, Harald Sommer, Klaus Pantel, Bernd Gerber, Klaus Friese	124
16	Immunocytochemical Detection and Characterization of Individual Micrometastatic Tumor Cells 2003 ·Humana Press eBooks ·Stephan Braun, Klaus Pantel	3
17	[Importance of occult metastatic cells in the treatment of patients with breast and gastrointestinal cancers]. 2002 ·PubMed ·Stephan Braun, Martina Auer, (unknown)	0
18	The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence 2001 ·Cancer ·Wolfgang Janni, F. Hepp, D. Rjosk, Christina Kentenich, B. Strobl, Christian Schindlbeck, Peer Hantschmann, Harald Sommer, Klaus Pantel, Stephan Braun	62
19	Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma 2000 ·Cancer ·Wolfgang Janni, (unknown), F. Hepp, Christina Kentenich, D. Rjosk, Christian Schindlbeck, T. Dimpfl, Harald Sommer, Stephan Braun	56
20	Tumor-antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease 1999 ·International Journal of Cancer ·Stephan Braun, F. Hepp, Harald Sommer, Klaus Pantel	93

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact